聚合诱导的排放:在肝细胞癌的诊断和治疗中的应用

Wenjing Xu1, Danfeng Jian2, Huang Yang3

  • 1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China; The Second Affiliated Hospital of Zhejiang University, Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, 310009, China; The Second Affiliated Hospital of Zhejiang University, Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang, 310009, China; Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease, Zhejiang University, Hangzhou, Zhejiang, 310009, China; The Second Affiliated Hospital of Zhejiang University Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang, 310009, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310009, China.

Biosensors & bioelectronics
|September 4, 2024
PubMed
概括

聚合诱导排放 (AIE) 为诊断和治疗肝细胞癌 (HCC) 提供了新的途径. 艾因基因在先进的成像,生物传感和光疗方面表现有前途,改善HCC患者的治疗结果.